An optimised lipid nanoparticle platform enables efficient CRISPR/Cas9 genome editing in hard-to-transfect cells
Open Access
- 28 May 2026
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 218, 432-444
Abstract
No abstract availableKeywords
Funding Information
- Cancer Institute NSW (IG240100774)
- National Health and Medical Research Council
- University of Technology Sydney
- Department of Education, Australian Government
This publication has 50 references indexed in Scilit:
- Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivoEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperaturesJournal of Controlled Release, 2023
- Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle deliveryAdvanced Drug Delivery Reviews, 2022
- CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerabilityLife Sciences, 2022
- Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugsActa Pharmaceutica Sinica B, 2022
- Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibitionJournal of Controlled Release, 2021
- Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single‐Cell ElectroporationSmall, 2018
- The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide deliveryAdvanced Drug Delivery Reviews, 2016
- Quantifying colocalization by correlation: The Pearson correlation coefficient is superior to the Mander's overlap coefficientCytometry Part A, 2010
- Freeze-drying of nanoparticles: Formulation, process and storage considerations☆Advanced Drug Delivery Reviews, 2006